NCT03735966 2022-12-01Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in HER2 Positive Breast Cancer Patients.Henan Cancer HospitalPhase 2 Completed75 enrolled
NCT02362958 2020-07-15A Multi-Center Study of Lapatinib in Patients With Trastuzumab-refractory Metastatic Breast CancerSun Yat-sen UniversityPhase 2 Completed159 enrolled